PROFUSA, INC. Proceeds from Notes Payable
PROFUSA, INC. (PFSA) reported Proceeds from Notes Payable of $11.00 million for the 12-month period ending 2025-12-31, per its S-1/A filed 2026-05-01.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2026-05-01
- PROFUSA, INC. proceeds from notes payable for the quarter ending 2025-12-31 was $0.00.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 derived: S-1/A 12 month − 10-Q 9 month · filed 2026-05-01 | $11.00M S-1/A · filed 2026-05-01 | |
| 2025-09-30 | $11.00M 10-Q · filed 2025-11-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |